Anjarium BioSciences
Schlieren, Switzerland · $61.0M raised
- Headquarters
- Schlieren
- Employees
- 11–50
- Business Model
- B2B
- Website
- anjarium.com
- Total Funding
- $61.0M
- Last Round
- $61.0M Series ASep 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Anjarium Biosciences is a Swiss cell and gene therapy tools company enabling next-generation gene therapies through proprietary delivery platforms.
Summary
Anjarium BioSciences is a Biotech company based in Schlieren, Switzerland. It has raised $61.0M in total across 1 round, most recently a $61.0M Series A round in Sep 2021. Investors include Gimv, Omega Funds and Pfizer Ventures.
Funding History
Sep 2021
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/anjarium-biosciences"><img src="https://indexed.vc/api/badge/company/anjarium-biosciences" alt="Anjarium BioSciences on Indexed.vc" width="260" height="76" /></a>